Vizz, Revolutionary Eye Drop for Presbyopia Treatment, Gains FDA Approval
The U.S. Food and Drug Administration (FDA) has recently approved a groundbreaking eye drop named Vizz, featuring the active ingredient “ascledin,” specifically designed to treat age-related near vision loss, known as presbyopia. Kabul 24: Presbyopia is a common condition that affects the eye’s ability to focus on close objects, typically.

